AtriCure
(NASDAQ:ATRC)
$23.39
-0.06[-0.26%]
At close: Apr 18
$23.39
0[0.00%]
After Hours: 4:20PM EDT
Q1 2024 Earnings in 13 days from now on Wed May 1st, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

AtriCure Stock (NASDAQ:ATRC), Quotes and News Summary

AtriCure Stock (NASDAQ: ATRC) stock price, news, charts, stock research, profile.

Open$23.370
Close$23.390
Volume / Avg.976.148K / 701.134K
Day Range22.870 - 23.690
52 Wk Range22.415 - 59.610
Market Cap$1.131B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
28
Short Interest
6.92%
Days to Cover4.29

Recent News

Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Sponsored
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Oct 23
3
Nov 23
1
Jan
3
Feb
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Atricure Inc
Sector
Health Care
Industry
Health Care Equipment & Supplies
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), le...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ATRC
NPCE

FAQ

Q

How do I buy AtriCure (ATRC) stock?

A

You can purchase shares of AtriCure (NASDAQ: ATRC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AtriCure's (ATRC) competitors?

A

Other companies in AtriCure’s space includes: NeuroPace (NASDAQ:NPCE), SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Inari Medical (NASDAQ:NARI) and Alphatec Holdings (NASDAQ:ATEC).

Q

What is the target price for AtriCure (ATRC) stock?

A

The latest price target for AtriCure (NASDAQ: ATRC) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 46.00 expecting ATRC to rise to within 12 months (a possible 96.67% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AtriCure (ATRC)?

A

The stock price for AtriCure (NASDAQ: ATRC) is $23.39 last updated Today at April 18, 2024 at 4:20 PM EDT.

Q

Does AtriCure (ATRC) pay a dividend?

A

There are no upcoming dividends for AtriCure.

Q

When is AtriCure (NASDAQ:ATRC) reporting earnings?

A

AtriCure’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is AtriCure (ATRC) going to split?

A

There is no upcoming split for AtriCure.

Q

What sector and industry does AtriCure (ATRC) operate in?

A

AtriCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch